ADC Therapeutics gets USFDA nod for ZYNLONTA to treat relapsed or refractory diffuse large B-cell…
First and only CD19-targeted antibody drug conjugate (ADC) as a single-agent treatment for adult patients with relapsed or…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.